173 related articles for article (PubMed ID: 36201890)
1. IL-7: Comprehensive review.
Winer H; Rodrigues GOL; Hixon JA; Aiello FB; Hsu TC; Wachter BT; Li W; Durum SK
Cytokine; 2022 Dec; 160():156049. PubMed ID: 36201890
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
[TBL] [Abstract][Full Text] [Related]
3. IL-7R-Dependent Phosphatidylinositol 3-Kinase Competes with the STAT5 Signal to Modulate T Cell Development and Homeostasis.
Cui G; Shimba A; Ma G; Takahara K; Tani-Ichi S; Zhu Y; Asahi T; Abe A; Miyachi H; Kitano S; Hara T; Yasunaga JI; Suwanai H; Yamada H; Matsuoka M; Ueki K; Yoshikai Y; Ikuta K
J Immunol; 2020 Feb; 204(4):844-857. PubMed ID: 31924648
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-7 promotes the survival of human CD4+ effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway.
Chetoui N; Boisvert M; Gendron S; Aoudjit F
Immunology; 2010 Jul; 130(3):418-26. PubMed ID: 20465565
[TBL] [Abstract][Full Text] [Related]
5. MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia.
Canté-Barrett K; Spijkers-Hagelstein JA; Buijs-Gladdines JG; Uitdehaag JC; Smits WK; van der Zwet J; Buijsman RC; Zaman GJ; Pieters R; Meijerink JP
Leukemia; 2016 Sep; 30(9):1832-43. PubMed ID: 27174491
[TBL] [Abstract][Full Text] [Related]
6. IL-7 activates the phosphatidylinositol 3-kinase/AKT pathway in normal human thymocytes but not normal human B cell precursors.
Johnson SE; Shah N; Bajer AA; LeBien TW
J Immunol; 2008 Jun; 180(12):8109-17. PubMed ID: 18523275
[TBL] [Abstract][Full Text] [Related]
7. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells.
Barata JT; Silva A; Brandao JG; Nadler LM; Cardoso AA; Boussiotis VA
J Exp Med; 2004 Sep; 200(5):659-69. PubMed ID: 15353558
[TBL] [Abstract][Full Text] [Related]
8. Direct interaction between Kit and the interleukin-7 receptor.
Jahn T; Sindhu S; Gooch S; Seipel P; Lavori P; Leifheit E; Weinberg K
Blood; 2007 Sep; 110(6):1840-7. PubMed ID: 17554063
[TBL] [Abstract][Full Text] [Related]
9. LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors.
Cheng Y; Chikwava K; Wu C; Zhang H; Bhagat A; Pei D; Choi JK; Tong W
J Clin Invest; 2016 Apr; 126(4):1267-81. PubMed ID: 26974155
[TBL] [Abstract][Full Text] [Related]
10. IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia.
Ribeiro D; Melão A; Barata JT
Adv Biol Regul; 2013 May; 53(2):211-22. PubMed ID: 23234870
[TBL] [Abstract][Full Text] [Related]
11. IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update.
Oliveira ML; Akkapeddi P; Ribeiro D; Melão A; Barata JT
Adv Biol Regul; 2019 Jan; 71():88-96. PubMed ID: 30249539
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow-derived mesenchymal stromal cells promote resistance to tyrosine kinase inhibitors in chronic myeloid leukemia via the IL-7/JAK1/STAT5 pathway.
Zhang X; Tu H; Yang Y; Jiang X; Hu X; Luo Q; Li J
J Biol Chem; 2019 Aug; 294(32):12167-12179. PubMed ID: 31235520
[TBL] [Abstract][Full Text] [Related]
13. The human IL-7 receptor gene: deletions, polymorphisms and mutations.
Mazzucchelli RI; Riva A; Durum SK
Semin Immunol; 2012 Jun; 24(3):225-30. PubMed ID: 22425228
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 7 receptor control of T cell receptor gamma gene rearrangement: role of receptor-associated chains and locus accessibility.
Durum SK; Candèias S; Nakajima H; Leonard WJ; Baird AM; Berg LJ; Muegge K
J Exp Med; 1998 Dec; 188(12):2233-41. PubMed ID: 9858510
[TBL] [Abstract][Full Text] [Related]
15. MEK1/2 induces STAT5-mediated germline transcription of the TCRgamma locus in response to IL-7R signaling.
Maki K; Ikuta K
J Immunol; 2008 Jul; 181(1):494-502. PubMed ID: 18566415
[TBL] [Abstract][Full Text] [Related]
16. Reconstitution of early lymphoid proliferation and immune function in Jak3-deficient mice by interleukin-3.
Brown MP; Nosaka T; Tripp RA; Brooks J; van Deursen JM; Brenner MK; Doherty PC; Ihle JN
Blood; 1999 Sep; 94(6):1906-14. PubMed ID: 10477719
[TBL] [Abstract][Full Text] [Related]
17. IL-2 negatively regulates IL-7 receptor alpha chain expression in activated T lymphocytes.
Xue HH; Kovanen PE; Pise-Masison CA; Berg M; Radovich MF; Brady JN; Leonard WJ
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13759-64. PubMed ID: 12354940
[TBL] [Abstract][Full Text] [Related]
18. INPP5K controls the dynamic structure and signaling of wild-type and mutated, leukemia-associated IL-7 receptors.
Moës B; Li H; Molina-Ortiz P; Radermecker C; Rosu A; Vande Catsyne CA; Sayyed SA; Fontela J; Duque M; Mostafa A; Azzi A; Barata JT; Merino R; Xu C; Desmet CJ; Schurmans S
Blood; 2023 Apr; 141(14):1708-1717. PubMed ID: 36599086
[TBL] [Abstract][Full Text] [Related]
19. Murine and human IL-7 activate STAT5 and induce proliferation of normal human pro-B cells.
Johnson SE; Shah N; Panoskaltsis-Mortari A; LeBien TW
J Immunol; 2005 Dec; 175(11):7325-31. PubMed ID: 16301638
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-7 and -15 maintain pathogenic memory Th17 cells in autoimmunity.
Chen Y; Chauhan SK; Tan X; Dana R
J Autoimmun; 2017 Feb; 77():96-103. PubMed ID: 27899224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
